trial

A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women

NCTId NCT03774641
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 10 (actual)
Sponsored by Johns Hopkins University
Primary completion 2024-04-16
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
10 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2018-12-03
Primary completion
2024-04-16
Eligibility
FEMALE · 18 Years

Interventions & indications

Drugs
Lamictal

Sponsors

Johns Hopkins UniversityLead Sponsor
National Institute on Aging (NIA)Collaborator

Investigators

1
Lindsay Standeven, MDPrincipal Investigator

Sites

1 total
Baltimore, United States

Facts & assertions

4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2024-04-16
Status
COMPLETED
relationships
The graph out of here
drug
Lamictal
drug
lead_sponsor
Johns Hopkins University
company
collaborator
National Institute on Aging (NIA)
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Major Depressive Disorder
indication
investigator
Lindsay Standeven, MD
person